Deferred Tax Assets, Valuation Allowance of BIOXYTRAN, INC from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BIOXYTRAN, INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • BIOXYTRAN, INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $3,276,000, a 19% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BIOXYTRAN, INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $3,276,000 +$529,147 +19% 31 Dec 2024 10-K 03 Apr 2025 2024 FY
Q4 2023 $2,746,853 +$802,555 +41% 31 Dec 2023 10-K 03 Apr 2025 2024 FY
Q4 2022 $1,944,298 +$544,298 +39% 31 Dec 2022 10-K/A 13 Jan 2025 2023 FY
Q4 2021 $1,400,000 +$722,618 +107% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $677,382 +$502,542 +287% 31 Dec 2020 10-K 11 Apr 2022 2021 FY
Q4 2019 $174,840 +$127,250 +267% 31 Dec 2019 10-K 09 Apr 2021 2020 FY
Q4 2018 $47,590 -$2,270,567 -98% 31 Dec 2018 10-K 18 Mar 2020 2019 FY
Q4 2017 $2,318,157 -$1,514,433 -40% 31 Dec 2017 10-K 02 Apr 2018 2017 FY
Q4 2016 $3,832,590 -$782,525 -17% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $4,615,115 +$735,045 +19% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q4 2014 $3,880,070 +$471,415 +14% 31 Dec 2014 10-K 20 Sep 2016 2015 FY
Q4 2013 $3,408,655 31 Dec 2013 10-K 10 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.